Piperacilina/Tazobactam Kabi

Medicinal product

(Invented) name

Active substance (s)

Piperacilinas/Tazobaktamas

Strength

4000 mg/500 mg

Pharmaceutical form

milteliai infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J01CR05, Piperacillin and beta-lactamase inhibitor

Marketing authorisation holder

UAB Adeofarma, Lietuva

Date of authorisation

2021-06-29

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Flakone yra	1 vnt.
Piperacilinas	4000 mg
Tazobaktamas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106753	92856	1092856	flakonas	N10	ASPĮ	Receptinis	LT/L/21/1547/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-06-29	Registruotas